Loading data for DMAA — first visit, this takes a few seconds.
Drugs Made In America Acq... (DMAA)
NasdaqGM: DMAA
· Precio en tiempo real · USD
10.72
+0.03 (0.28%)
Al cierre: Aug 18, 2026, 8:00 PM
Drugs Made In America Acquisition Corp. (DMAA) Stock Price, Analysis & Data
0.28% (1D)
No hay datos disponibles
| Precio de compra | 10.65 |
| Capitalización de mercado | 260.25M |
| Ingresos (TTM) | n/a |
| Beneficio neto (TTM) | 6.66M |
| Beta | n/a |
| EPS (TTM) | 0.18 |
| Ratio PER (TTM) | 59.56 |
| Adelante PE | n/a |
| P/B (TTM) | -49.86 |
| P/S (TTM) | n/a |
| Earnings Date | n/a |
| Precio de venta | 10.54 |
| Volumen | 24,959 |
| Volumen medio (20D) | 35,809 |
| Abierto | 10.72 |
| Anterior Cerrar | 10.69 |
| Rango del día | 10.72 - 10.72 |
| Rango de 52 semanas | 10.22 - 10.72 |
| analista | n/a |
| Precio objetivo | n/a |
| Dividendos | n/a |
| Fecha ex dividendo | n/a |
Acerca de DMAA
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York....
Industria Shell Companies
Sector Financial Services
IPO Fecha Feb 25, 2025
Empleados n/a
Bolsa de Valores NasdaqGM
Símbolo bursátil DMAA
Desempeño financiero
En 2025, los ingresos de Drugs Made In America Acquisition fueron 0, un aumento de undefined% en comparación con n/a del año anterior. Las ganancias fueron 5.94M, un aumento de undefined%.
Estados financieros